-The Times of India Retail giant Walmart has disclosed that it is investigating alleged violations of the US anti-bribery law in India, China and Brazil. The development could trigger fresh opposition to the opening up of the domestic retail market to global companies. The disclosure is likely to provide ammunition to political parties that are planning to corner the government on its decision to allow FDI in multi-brand retail when Parliament reconvenes...

(Application deadline Monday December 31, 2012) Inclusive Media for Change, a CSDS-based initiative invites applications from journalists in English and Hindi for Inclusive Media Fellowships 2012-13. The Fellowships are given to bring spotlight on Rural Development and to promote democratic social change, particularly through empowerment, decentralization, convergence and good use of existing development schemes by Panchayats and local bodies. The Inclusive Media for Change runs a clearing house of ideas, information...

-WeeklyBlitz.net As India is approaching towards a general election in less than a year, the leader of ruling Indian National Congress has been listed as world's fourth richest politician with a total wealth of over US$ 18 billion, which is invested in real estate, telecommunication and various business projects around the world, while significant portion of the amount is also deposited in secret bank accounts. Italian born Indian politician Sonia Gandhi...

-Pratirodh.com The fanfare with which Prime Minister Manmohan Singh and Congress president Sonia Gandhi launched a service delivery scheme in Rajasthan based on the Aadhaar (foundation) unique identity (UID), and celebrated the issue of the first Aadhaar number topping the 200-million mark, should make the Indian National Congress a very worried party indeed—assuming it has a good survival instinct and basic grasp of practical politics.    To put it starkly, the Congress and...

-The Economic Times MUMBAI: A drug maker found overcharging will have to shell out the entire sales revenue of the medicine from the date of its launch as penalty, according to a directive issued by the country's drug price regulator. "If a company has not been booked for overcharging for selling the product without price approval, if any, pertaining to the period prior to fixation of the price of the said formulation,...